Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 162 participants.
Also called NCT06643130
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 162 participants
- Sponsor
- Registry
-
NCT06643130
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06643130. Randomized; quadruple masking; primary purpose treatment. Start 2024-12-02 (actual); primary completion 2026-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
- Condition
- Hypertension
- Condition
- Dyslipidemia
- Intervention (Drug)
- JW0104+C2402
- Intervention (Drug)
- JW0104+C2403
- Intervention (Drug)
- C2402
- Lead sponsor
- JW Pharmaceutical
Record details
- Record id
cardio:ct-nct06643130- Content hash
53dad54b564d19cf6ce068bb3c73a12c69f4d1aa036c93fd9988a40484664770